Table 2 Demographic characteristics of individuals diagnosed with hypertension in the period 2017–2019 and in the period 2020–2022. Data presented as mean (SD) and confidence interval for continuous variables and as absolute frequency (percentage) for categorical variables
Variable | 2017–2019 N = 12,820 | 95% CI | 2020–2022 N = 29,523 | 95% CI |
|---|---|---|---|---|
Age (years) | 66 (14) | 65.9, 66.4 | 66 (14) | 66, 67 |
Glycemia (mg/dl) | 97 (15) | 96, 97 | 98 (15) | 97, 98 |
Hb1Ac (%) | 6.17 (0.77) | 6.1, 6.2 | 6.23 (0.78) | 6.2, 6.3 |
Sex | ||||
F | 6830 (53%) | 52%, 54% | 16,078 (54%) | 54%, 55% |
M | 5978 (47%) | 46%, 48% | 13,435 (46%) | 45%, 46% |
Current or former smoking | ||||
NO | 4924 (73%) | 71%, 74% | 6496 (73%) | 72%, 74% |
YES | 1867 (27%) | 26%, 29% | 2388 (27%) | 26%, 28% |
BMI (kg/m2) | 26.6 (3.7) | 26, 27 | 26.5 (3.5) | 26, 27 |
Creatinine (mg/dl) | 0.89 (0.20) | 0.89, 0.90 | 0.90 (0.21) | 0.90, 0.91 |
ALT (mU/ml) | 20 (8) | 20, 21 | 20 (8) | 20.0, 20.4 |
AST (mU/ml) | 21 (6) | 20, 21 | 20 (6) | 20, 21 |
Cancer | ||||
NO | 8987 (70%) | 69%, 71% | 23,470 (79%) | 79%, 80% |
YES | 3833 (30%) | 29%, 31% | 6053 (21%) | 20%, 21% |
COPD | ||||
NO | 12,072 (94.2%) | 94%, 95% | 27,504 (93.2%) | 92.9%, 93.4% |
YES | 748 (5.8%) | 5.4%, 6.3% | 2019 (6.8%) | 6.6%, 7.1% |
Hypercholesterolemia | ||||
NO | 9812 (77%) | 76%, 77% | 23,224 (79%) | 78%, 79% |
YES | 3008 (23%) | 23%, 24% | 6299 (21%) | 21%, 22% |
Hypertriglyceridemia | ||||
NO | 12,433 (97%) | 96.7%, 97.3% | 28,976 (98.1%) | 98.0%, 98.3% |
YES | 387 (3%) | 2.7%, 3.3% | 547 (1.9%) | 1.7%, 2.0% |
COVID-19 | ||||
NO | 26,019 (88%) | 87.8%, 88.5% | ||
YES | 3504 (12%) | 11.5%, 12.2% | ||